3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Papillomavirus Infections
7
Uterine Cervical Neoplasms
5
Neuroendocrine Tumors
4
Neoplasms
4
Autoimmune Diseases
3
Ovarian Neoplasms
2
Myasthenia Gravis
2
Mesothelioma, Malignant
2
Lung Neoplasms
2
Venous Thrombosis
1
Venous Thromboembolism
1
Uterine Cervical Dysplasia
1
Thyroid Diseases
1
Thrombosis
1
Squamous Intraepithelial Lesions
1
Retinal Telangiectasis
1
Renal Insufficiency
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mesothelioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphohistiocytosis, Hemophagocytic
1
Leukemia, Hairy Cell
1
Hemorrhage
1
Hematologic Neoplasms
1
Glioma
1
Glioblastoma
1
Interventions
Dexamethasone
7
Bortezomib
4
Lenalidomide
3
pomalidomide
2
glucarpidase
2
Kidney Transplantation
2
Bendamustine Hydrochloride
2
Azacitidine
2
vinflunine
1
trifluridine tipiracil drug combination
1
trebananib
1
safinamide
1
sacubitril and valsartan sodium hydrate drug combination
1
rubitecan
1
ripretinib
1
regorafenib
1
pevonedistat
1
osimertinib
1
mirabegron
1
gamma-Glutamyl Hydrolase
1
copanlisib
1
carfilzomib
1
Zoledronic Acid
1
Urinalysis
1
Topotecan
1
Thalidomide
1
Tablets
1
Stents
1
Sitagliptin Phosphate
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Renal Insufficiency
×
Data Collection
×
Clear all
NCT03234335
2023-05-06
IRMYG
Centre Hospitalier Universitaire de Saint Etienne
Completed
50 enrolled